| Literature DB >> 23578338 |
Yi Li1, Xiaolei Shi, Xiaoming Rong, Ying Peng, Yamei Tang.
Abstract
BACKGROUND: Radiotherapy is the standard radical treatment for nasopharyngeal carcinoma (NPC) and may cause radiation-induced brain injury (RI). Treatment for RI remains a challenge. We conducted this study to investigate the indications of neurosurgery, operation time and prognosis of patients with RI after NPC radiotherapy who underwent neurosurgical management.Entities:
Mesh:
Year: 2013 PMID: 23578338 PMCID: PMC3653741 DOI: 10.1186/1748-717X-8-88
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Demographic Data of RI patients underwent surgery (N = 15, in years)
| 1 | 53y | M | 0.5 | 144 | 68 | Faciocervical | N | 52 | Survival |
| 2 | 57y | M | 5 | 36 | 76 | Faciocervical | N | 39 | Survival |
| 3 | 57y | M | 7 | 36 | 70 | Preauricular | N | 32 | Survival |
| 4 | 60y | M | 2 | 3 | 70 | Faciocervical | N | 25 | Died |
| 5 | 28y | M | 3 | 10 | 68 | Preauricular | N | 30 | Survival |
| 6 | 58y | F | 13 | 12 | 66 | Faciocervical | N | 8 | Died |
| 7 | 48y | M | 3 | 5 | 70 + 68 | Faciocervical | Y | 6 | Survival |
| 8 | 57y | F | 5 | 12 | 72 | Faciocervical | N | 60 | Survival |
| 9 | 42y | M | 4 | 11 | 68 + 68 | Faciocervical | Y | 11 | Survival |
| 10 | 53y | M | 4 | 11 | 68 + 68 | Faciocervical | Y | 13 | Survival |
| 11 | 42y | M | 2 | 24 | 70 | Preauricular | N | 41 | Survival |
| 12 | 65y | M | 7 | 12 | 70 | Preauricular | N | 27 | Survival |
| 13 | 51y | M | 3 | 36 | 68 | Faciocervical | N | 71 | Survival |
| 14 | 48y | M | 2 | 24 | 70 | Faciocervical | N | 20 | Survival |
| 15 | 50y | M | 5 | 22 | 74 | Faciocervical | N | 22 | Survival |
1 Interval between radiation and diagnosis of RI (for the patients who underwent reirradiation, this was the interval between reirradiation and diagnosis of RI).
2 Interval between diagnosis of RI and surgery.
MRI characteristics in RI patients underwent surgery
| Multiple brain lobes | 7 | |
| Temporal lobe | Bilateral | 7 |
| Unilateral | 1 | |
| Brain stem | 2 | |
| Cyst | 9 | |
| Mass effect and/or shift of the midline | 7 | |
Type of surgical procedure
| Case number | 13 | 2 | 15 |
Pathology
| 1 | + | - | - | + | - | - |
| 2 | + | + | + | + | - | - |
| 3 | + | + | - | + | - | - |
| 4 | + | + | + | - | - | - |
| 5 | + | + | + | - | + | + |
| 6 | + | + | - | - | - | - |
| 7* | - | - | - | - | - | - |
| 8 | + | - | + | - | + | - |
| 9 | + | + | + | + | - | - |
| 10* | - | - | - | - | - | - |
| 11 | + | + | + | - | - | - |
| 12 | + | + | + | + | - | - |
| 13 | + | - | + | - | + | - |
| 14 | + | + | + | + | - | - |
| 15 | + | + | - | - | - | - |
| Total | 13 | 10 | 9 | 6 | 3 | 1 |
* These two cases were performed decompressive craniotomy and pathological results were not displayed.
Score increment of LENT/SOMA scales and modified Rankin scale before and after sugery
| LENT SOMA (case number) | Subjective | 0 | 5 | 8 | 2 |
| Objective | 2 | 3 | 7 | 3 | |
| Management | 3 | 6 | 5 | 1 | |
| Analytic | 5 | 7 | 2 | 1 | |
| Rankin (case number) | 0 | 5 | 7 | 3 | |
Multiple logistic regression analysis of age, gender, post-RT intervals, radiation dose, radiation field, brain MRI, surgery, pathology to predict clinical outcome
| Age | 1.799 | 1 | 0.180 | |
| Gender | 2.685 | 1 | 0.101 | |
| Interval 1(year) 1 | 2.671 | 1 | 0.102 | |
| Interval 2 (month) 2 | 1.057 | 1 | 0.304 | |
| Radiation dose (Gy) | 0.774 | 1 | 0.379 | |
| Radiation field | 0.839 | 1 | 0.360 | |
| Surgery | 0.355 | 1 | 0.551 | |
| Brain MRI foci | Multiple brain lobes | 2.637 | 1 | 0.104 |
| Bilateral temporal lobes | 2.019 | 1 | 0.155 | |
| Unilateral temporal lobe | 0.165 | 1 | 0.685 | |
| Brain stem | 0.355 | 1 | 0.551 | |
| Cyst | 3.462 | 1 | 0.063 | |
| Mass effect and/or shift of the midline | 2.637 | 1 | 0.104 | |
| Pathology | Brain necrosis | 0.709 | 1 | 0.400 |
| Gliosis | 0.410 | 1 | 0.522 | |
| Small vascular proliferation | 2.026 | 1 | 0.155 | |
| Haemorrhage | 0.709 | 1 | 0.400 | |
| Edema | 0.197 | 1 | 0.657 | |
| Infiltration of inflammatory cells | 5.318 | 1 | 0.378 | |
Dependent: clinical outcome (survival or died).
1 Interval between radiation and diagnosis of RI (for the patients who underwent reirradiation, this was the interval between reirradiation and diagnosis of RI).
2 Interval between diagnosis of RI and surgery.